| Product NDC: | 25021-703 |
| Proprietary Name: | Sumatriptan Succinate |
| Non Proprietary Name: | sumatriptan succinate |
| Active Ingredient(s): | 6 mg/.5mL & nbsp; sumatriptan succinate |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-703 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090641 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110101 |
| Package NDC: | 25021-703-60 |
| Package Description: | 5 VIAL in 1 CARTON (25021-703-60) > .5 mL in 1 VIAL |
| NDC Code | 25021-703-60 |
| Proprietary Name | Sumatriptan Succinate |
| Package Description | 5 VIAL in 1 CARTON (25021-703-60) > .5 mL in 1 VIAL |
| Product NDC | 25021-703 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sumatriptan succinate |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20110101 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | SUMATRIPTAN SUCCINATE |
| Strength Number | 6 |
| Strength Unit | mg/.5mL |
| Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |